Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MINI-AMI: Minimizing Infarct Size With Impella 2.5 Following PCI for Acute Myocardial Infarction (MINI-AMI)

This study has been terminated.
(Change in business priority)
Information provided by (Responsible Party):
Abiomed Inc. Identifier:
First received: March 18, 2011
Last updated: May 1, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: August 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)